BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 25787823)

  • 41. Cellular uptake of Aib-containing amphipathic helix peptide.
    Wada S; Tsuda H; Okada T; Urata H
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5688-91. PubMed ID: 21875799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current Understanding of Direct Translocation of Arginine-Rich Cell-Penetrating Peptides and Its Internalization Mechanisms.
    Takeuchi T; Futaki S
    Chem Pharm Bull (Tokyo); 2016; 64(10):1431-1437. PubMed ID: 27725497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Advances in the research and application of cell penetrating peptides].
    Xie Y; Wang S; Yuan Q; Xie N
    Sheng Wu Gong Cheng Xue Bao; 2019 Jul; 35(7):1162-1173. PubMed ID: 31328473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
    Dissanayake S; Denny WA; Gamage S; Sarojini V
    J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In Vitro Assays: Friends or Foes of Cell-Penetrating Peptides.
    Liu J; Afshar S
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
    Fonseca SB; Pereira MP; Kelley SO
    Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Empowering the Potential of Cell-Penetrating Peptides for Targeted Intracellular Delivery via Molecular Self-Assembly.
    Shi Y; Conde J; Azevedo HS
    Adv Exp Med Biol; 2017; 1030():265-278. PubMed ID: 29081058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell-penetrating peptides in the intracellular delivery of viral nanoparticles.
    Hejtmánková A; Váňová J; Španielová H
    Vitam Horm; 2021; 117():47-76. PubMed ID: 34420585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SCARA Involvement in the Uptake of Nanoparticles Formed by Cell-Penetrating Peptides.
    Helmfors H; Lindberg S; Langel Ü
    Methods Mol Biol; 2015; 1324():163-74. PubMed ID: 26202269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonhemolytic Cell-Penetrating Peptides: Site Specific Introduction of Glutamine and Lysine Residues into the α-Helical Peptide Causes Deletion of Its Direct Membrane Disrupting Ability but Retention of Its Cell Penetrating Ability.
    Kim S; Hyun S; Lee Y; Lee Y; Yu J
    Biomacromolecules; 2016 Sep; 17(9):3007-15. PubMed ID: 27442521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modeling the endosomal escape of cell-penetrating peptides using a transmembrane pH gradient.
    Madani F; Abdo R; Lindberg S; Hirose H; Futaki S; Langel U; Gräslund A
    Biochim Biophys Acta; 2013 Apr; 1828(4):1198-204. PubMed ID: 23261392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Considerations on the Rational Design of Covalently Conjugated Cell-Penetrating Peptides (CPPs) for Intracellular Delivery of Proteins: A Guide to CPP Selection Using Glucarpidase as the Model Cargo Molecule.
    Behzadipour Y; Hemmati S
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nanoparticles-cell-penetrating peptide.
    Dowaidar M; Nasser Abdelhamid H; Hällbrink M; Langel Ü; Zou X
    J Biomater Appl; 2018 Sep; 33(3):392-401. PubMed ID: 30223733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.
    Patel LN; Zaro JL; Shen WC
    Pharm Res; 2007 Nov; 24(11):1977-92. PubMed ID: 17443399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell entry of cell penetrating peptides: tales of tails wagging dogs.
    Jones AT; Sayers EJ
    J Control Release; 2012 Jul; 161(2):582-91. PubMed ID: 22516088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Versatility of cell-penetrating peptides for intracellular delivery of siRNA.
    Singh T; Murthy ASN; Yang HJ; Im J
    Drug Deliv; 2018 Nov; 25(1):1996-2006. PubMed ID: 30799658
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell-penetrating peptides: design, synthesis, and applications.
    Copolovici DM; Langel K; Eriste E; Langel Ü
    ACS Nano; 2014 Mar; 8(3):1972-94. PubMed ID: 24559246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.
    Hemmati S; Behzadipour Y; Haddad M
    Infect Genet Evol; 2020 Nov; 85():104474. PubMed ID: 32712315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.
    Kurrikoff K; Gestin M; Langel Ü
    Expert Opin Drug Deliv; 2016; 13(3):373-87. PubMed ID: 26634750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How Cargo Identity Alters the Uptake of Cell-Penetrating Peptide (CPP)/Cargo Complexes: A Study on the Effect of Net Cargo Charge and Length.
    Hymel HC; Rahnama A; Sanchez OM; Liu D; Gauthier TJ; Melvin AT
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.